Search results
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga via Yahoo Finance· 23 hours agoOn Monday, Moderna (NASDAQ: MRNA) and Merck & Co (NYSE: MRK) also reported durable efficiency of...
US approves Moderna's RSV vaccine for older adults
AFP via Yahoo News· 5 days agoThe US Food and Drug Administration on Friday approved Moderna's respiratory syncytial virus (RSV) vaccine for older adults -- marking the first time any...
Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA(R)
The Joplin Globe· 5 days agomRESVIA is Moderna's second approved product and the only RSV vaccine available in single-dose pre-filled syringes
Is Moderna Stock A Buy As The U.S. Government Mulls Its Bird Flu Vaccine?
Investor's Business Daily· 5 days agoIf approved, Moderna plans to launch its RSV vaccine this fall for people age 60 and older, rivaling...
What To Know About Personalized mRNA Cancer Vaccines After Promising Trials From Moderna And Merck
Forbes· 1 day agoCancer vaccines are finally showing promise as Moderna and Merck touted promising data on an...
The Sustained, Slow Declining, Blood Concentration Profile of NV-387 Enables Infrequent Dosing for...
Morningstar· 1 day agoThe Company has found that its lead nanoviricide broad-spectrum antiviral drug candidate NV-387, when given as a slow bolus intravenous infusion, resulted in a relatively flat plateau of blood ...
1 Beaten-Down S&P 500 Dividend Stock to Buy in June and Hold For a Decade or Longer
Motley Fool via Yahoo Finance· 1 day agoThat was an 81% risk reduction compared to trial participants who were randomized to receive...
Experimental mRNA vaccines gain steam with promising cancer trial results
Semafor via Yahoo News· 2 days agoMelanoma patients who received monthly mRNA vaccines and...the US Food and Drug Administration for...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 7 days agoIt will cost $3.5 million for a one-time treatment. And European regulators gave Pfizer the nod for...
Analysis | Four questions for today’s Fauci hearing
Washington Post· 2 days agoThe Texas Supreme Court rejected a lawsuit that sought to clarify exceptions to the state’s abortion laws. The longtime infectious-disease expert is back...